| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5572102 | Clinical Nutrition | 2017 | 6 Pages |
Abstract
GPR119 is an early transcriptional responder to duodenal lipid in lean humans, although this response appeared reduced in individuals with high PUFA intake. These observations may have implications for downstream regulation of gut hormone secretion and appetite. This study was registered as a clinical trial with the Australia and New Zealand Clinical Trial Registry (Trial number: ACTRN12612000376842).
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Nada Cvijanovic, Nicole J. Isaacs, Christopher K. Rayner, Christine Feinle-Bisset, Richard L. Young, Tanya J. Little,